Through
4/26
Cancer Research
Cancer screening rates decline when patients see doctors later in day
Cancer screening rates decline when patients see doctors later in day
Compared to patients who see their primary care doctor earlier in the day, cancer screening rates decline significantly as the day goes on, according to a new study from researchers in the Perelman School of Medicine and Wharton School.
The cancer-body clock connection
The cancer-body clock connection
Researchers at the Perelman School of Medicine show how disruptions to the circadian rhythm influence tumor growth and cancer treatment.
Two Penn faculty elected to the National Academy of Sciences
Two Penn faculty elected to the National Academy of Sciences
Eugene Mele of the School of Arts and Sciences and Nancy Speck of the Perelman School of Medicine are welcomed into the Academy for their “distinguished and continuing achievements in original research.”
Expanding opportunities to leverage science in the clinic
Expanding opportunities to leverage science in the clinic
Patricia Corby, who recently joined the School of Dental Medicine as associate dean for translational research, is bringing her research to bear for cancer patients undergoing radiation, while looking to advance clinical research School-wide.
Topical targeted therapies show promise in treatment of skin cancer
Topical targeted therapies show promise in treatment of skin cancer
A Penn study finds fewer side effects with small-molecule kinase inhibitors compared to standard ointment when treating precancerous skin lesions.
The Power of Penn at the Met
The Power of Penn at the Met
One year into the Power of Penn campaign, President Amy Gutmann hosted a panel discussion with three professors to usher in another year of inclusion, innovation, and impact on a local and global scale.
Cancer most frequently spreads to the liver. Here’s why.
Cancer most frequently spreads to the liver. Here’s why.
Researchers from the Abramson Cancer Center shows hepatocytes, the chief functional cells of the liver, orchestrate the “seed and soil” process for cancer to spread to the liver.
For melanoma patients, one dose of immunotherapy before surgery can lead to remission
For melanoma patients, one dose of immunotherapy before surgery can lead to remission
An Abramson Cancer Center study finds that with a single dose of a PD-1 inhibitor, immune responses can peak in just one week.
25 years of integration, innovation, and ideals
25 years of integration, innovation, and ideals
2018 marked 25 years since the University of Pennsylvania Health System (UPHS) was first established—a milestone that would undoubtedly make the institution’s founder, Benjamin Franklin, proud.
Energizing the immune system to eat cancer
Energizing the immune system to eat cancer
An Abramson Cancer Center study identifies a method of priming macrophages to boost an anti-tumor response wherein macrophages attack and eat cancer cells.
In the News
CNN
There’s still no standard test to detect pancreatic cancer early. Scientists are working to change that
A 2020 study from the Perelman School of Medicine found that a blood test to screen for certain biomarkers associated with pancreatic cancer was 92% accurate in its ability to detect disease.
FULL STORY →
Associated Press
A new strategy to attack aggressive brain cancer shrank tumors in two early tests
A clinical trial led by Stephen Bagley of the Perelman School of Medicine suggests that targeting two associated proteins with CAR T cell therapy could be a viable strategy for shrinking brain tumors.
FULL STORY →
Philadelphia Inquirer
UPenn scientists among those developing vaccines that arm the immune system to fight cancer
Penn Medicine researchers like Nobel laureate Drew Weissman are leading efforts to develop a vaccine that prevents cancer, with remarks from Susan Domchek of the Basser Center for BRCA and Robert H. Vonderheide of the Abramson Cancer Center.
FULL STORY →
Philadelphia Inquirer
Penn’s BRCA cancer vaccine trial aims to prevent the disease in healthy people
A trial led by Susan Domchek of the Perelman School of Medicine could use a preventive vaccine to protect people with a BRCA gene mutation from cancer.
FULL STORY →
Psychology Today
AI detects cancers and immunotherapy biomarker
Daiwei Zhang and Mingyao Li of the Perelman School of Medicine and colleagues have developed an AI tool called iStar that can automatically spot tumors and types of cancer that are difficult for clinicians to see or identify and can predict candidates for immunotherapy.
FULL STORY →
Philadelphia Inquirer
Penn started giving cancer patients free rides to appointments. It helped reduce no-shows and increase clinical trial enrollment
The Abramson Cancer Center is attempting to address one of the most common challenges cancer patients face: lack of transportation to critically important appointments. Robert Vonderheide and Carmen Guerra of the Perelman School of Medicine are quoted on the Ride Health initiative.
FULL STORY →